Michael Gao, MD, CEO and co-founder of SmarterDx
Applying artificial intelligence (AI) solutions in hospitals and health systems can be overwhelming for leaders due to AI’s complexity (it’s not one technology, but several) and rapid…
Continue Reading
Avenda Health’s groundbreaking Unfold AI platform represents a monumental advancement in prostate cancer management, enabling unparalleled precision and personalized treatment strategies. Through sophisticated AI algorithms, Unfold AI integrates patient-specific data to generate comprehensive cancer…
Continue Reading
The study evaluates the effectiveness of Epic’s Risk of hospital-acquired acute kidney injury (HA-AKI) model, utilizing data from a cohort within the Mass General Brigham network. Despite demonstrating moderate success in predicting HA-AKI, the…
Continue Reading
Drug repurposing represents an attractive alternative to the costly and time-consuming process of new drug development, particularly for serious, widespread conditions with limited effective treatments, such as Alzheimer’s disease (AD). Emerging generative artificial intelligence…
Continue Reading
Researchers at the University of Konstanz, supported by a Proof of Concept Grant, are pioneering a liquid dosimeter for improved radiotherapy quality control. Leveraging small probe molecules sensitive to radiation, encapsulated in water-filled capsules,…
Continue Reading
In the realm of healthcare, trust in AI looms as a significant challenge and an essential puzzle to solve. With technological advancements like ChatGPT and large language models (LLMs), the healthcare sector is brimming…
Continue Reading
What You Should Know:
– Mass General Brigham, a healthcare provider, and Annalise.ai, a global medical imaging AI company, today announced a strategic collaboration to develop and implement AI-enabled diagnostic products.
– This strategic partnership aims…
Continue Reading
A groundbreaking method developed by the University of Gothenburg bridges the diagnostic gap between CT and MRI scans. Utilizing AI, this innovative software enhances CT images to rival the quality of MRI scans, particularly…
Continue Reading
Modern management of MS targets No Evidence of Disease Activity (NEDA): no clinical relapses, no magnetic resonance imaging (MRI) disease activity and no disability worsening. While MRI is the principal tool available to neurologists…
Continue Reading
Children’s Mercy Hospital in Kansas City has achieved a breakthrough in pediatric genomics by developing a process for conducting whole-genome sequencing tests within clinical settings. Dr. Tomi Pastinen, director of its Genomic Medicine Center,…
Continue Reading
